EC145: a novel targeted agent for adenocarcinoma of the lung.
about
Targeting folate receptor alpha for cancer treatmentMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryVintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Expression of high affinity folate receptor in breast cancer brain metastasis.Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.Prospects in folate receptor-targeted radionuclide therapyEnhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expressionClinical translation of folate receptor-targeted therapeutics.Natural product and natural product derived drugs in clinical trials.Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.Synthesis and evaluation of hybrid molecules targeting the vinca domain of tubulin.Vintafolide: a novel targeted agent for epithelial ovarian cancer.Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Müllerian origin, and primary lung adenocarcinoma.Development of a Novel Covalent Folate-Albumin-Photosensitizer Conjugate.
P2860
Q26744215-DDDFED93-1CC0-4EF4-9B06-86BF3A5D9EA4Q26852723-E863013B-C3AF-4F74-86BB-7D17162DAC1FQ35780797-9B867843-AF7C-4A01-88E7-88E93A65FB85Q35854305-4D12C71C-9E6D-4503-930D-52EA07D18A76Q36557588-AA11410D-589F-49AA-AEB2-F32369CC642CQ36821156-A81948C3-0021-4FBD-8861-FDFE74C8E8B0Q37193061-701DD24F-B109-4F6E-AD25-AA8327BAD60FQ37553497-EC979E2B-8549-46E4-804D-8E759C67490DQ38015901-FEB6F399-9951-4894-A7B7-09B3665BD7A8Q38247457-4050ABB9-A603-4423-B489-5EED9322F556Q38524502-AB18EDB7-2DAF-41A6-8509-7CBEC39F6238Q38915043-EB5ACC8A-3BFB-439C-B57E-F614F692F4FBQ39205772-39859A3B-0D32-452C-819C-33E54F02ABECQ39997968-E85855A8-4A16-4F65-8901-DAF20770A42EQ50849796-B39E1B61-7A59-467A-B2EF-FD889D9903F2
P2860
EC145: a novel targeted agent for adenocarcinoma of the lung.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
EC145: a novel targeted agent for adenocarcinoma of the lung.
@en
EC145: a novel targeted agent for adenocarcinoma of the lung.
@nl
type
label
EC145: a novel targeted agent for adenocarcinoma of the lung.
@en
EC145: a novel targeted agent for adenocarcinoma of the lung.
@nl
prefLabel
EC145: a novel targeted agent for adenocarcinoma of the lung.
@en
EC145: a novel targeted agent for adenocarcinoma of the lung.
@nl
P2860
P1476
EC145: a novel targeted agent for adenocarcinoma of the lung.
@en
P2093
Martin J Edelman
Pamela Pribble
P2860
P304
P356
10.1517/13543784.2012.671294
P407
P577
2012-03-30T00:00:00Z